长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02652 长风药业

未开盘 06-09 16:08:13

19.050

-0.950

-4.75%

最高20.500	最低18.210	成交量125.20万
今开20.500	昨收20.000	日振幅11.45%
总市值78.30亿	流通市值57.53亿	总股本4.11亿
成交额2,374万	换手率0.41%	流通股本3.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"长风药业","latestPrice":19.05,"timestamp":1780992493004,"preClose":20,"halted":0,"volume":1252000,"delay":0,"changeRate":-0.047499999999999966,"floatShares":302000000,"shares":411000000,"eps":0.0076318803780505,"marketStatus":"未开盘","change":-0.95,"latestTime":"06-09 16:08:13","open":20.5,"high":20.5,"low":18.21,"amount":23743770,"amplitude":0.1145,"askPrice":19.11,"askSize":2000,"bidPrice":19.05,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.0076318803780505,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781055000000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":20,"openAndCloseTimeList":[[1780968600000,1780977600000],[1780981200000,1780992000000]],"volumeRatio":2.7039868689929585,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02652","defaultTab":"news","newsList":[{"id":"1112306701","title":"长风药业6月9日回购3.10万股股份，耗资约58.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112306701","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112306701?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:16","pubTimestamp":1781007366,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年6月9日公告，基于已获批准的股份回购授权，于香港联交所场内回购31,000股普通股。本次回购股份约占公司回购前已发行股本总数的0.0103%。每股回购价介乎每股18.52港元至19.14港元，合计支付总金额约58.61万港元。公司表示，本次回购基于2025年12月16日股东大会通过的股份回购授权，授权回购股份总数为30,222,358股，截至公告日已依据该授权累计回购1,300,000股，占授权生效时公司已发行股份总数的0.4301%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业6月9日回购3.10万股股份，耗资约58.61万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642946792","title":"长风药业(02652)6月9日斥资58.6万港元回购3.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642946792","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642946792?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:11","pubTimestamp":1781007087,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年6月9日斥资58.6万港元回购3.1万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452172.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118983010","title":"长风药业(02652)6月5日回购1.95万股股份，涉资约39.61万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118983010","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118983010?lang=zh_cn&edition=full","pubTime":"2026-06-05 19:15","pubTimestamp":1780658149,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年6月5日公告回购股份。该公司当日在香港联交所场内回购H股1.95万股，占此前已发行股本0.0065%，每股回购价格介乎20.04港元至20.68港元，总金额约39.61万港元。公司本次回购基于2025年12月16日获得的购回授权，该授权允许公司回购股份总数为30,222,358股。截至本公告日，公司已根据该授权买回1,269,000股。本公告由公司执行董事及联席公司秘书朱玉玉签署，公告日期为2026年6月5日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业(02652)6月5日回购1.95万股股份，涉资约39.61万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640168371","title":"长风药业(02652)：吸入制剂生产基地通过PIC/S成员国GMP检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2640168371","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640168371?lang=zh_cn&edition=full","pubTime":"2026-06-04 21:19","pubTimestamp":1780579155,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 公布，集团位于中国苏州的吸入制剂生产基地近期通过由国际药品检查合作计划组织成员国的药品监督管理机构所进行的现场药品生产质量管理规范合规检查。通过是次检查，确认该基地的质量管理体系及生产能力符合PIC/S GMP标准，为集团的吸入制剂开启重要的市场准入渠道。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135095040","title":"长风药业6月4日回购3.35万股股份，总额约68.43万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135095040","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135095040?lang=zh_cn&edition=full","pubTime":"2026-06-04 21:05","pubTimestamp":1780578343,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年6月4日发布翌日披露报表，公司于当日在香港联交所场内回购股份。此次回购涉及33,500股，占回购前公司已发行股本约0.0111%，每股回购价介乎19.97港元至21.04港元，总金额约68.43万港元。长风药业的购回授权于2025年12月16日获通过，授权可回购的股份总数为30,222,358股，截至目前合计已回购1,249,500股。公司确认已遵守香港联交所证券上市规则及相关法律法规开展上述回购事项。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业6月4日回购3.35万股股份，总额约68.43万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640247150","title":"长风药业(02652)6月4日耗资约68.43万港元回购3.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640247150","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640247150?lang=zh_cn&edition=full","pubTime":"2026-06-04 21:03","pubTimestamp":1780578189,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)公布，2026年6月4日耗资约68.43万港元回购3.35万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640613294","title":"港股异动 | 长风药业(02652)涨超5% 近日ICF004吸入粉雾剂I类新药IND申请获NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2640613294","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640613294?lang=zh_cn&edition=full","pubTime":"2026-06-04 14:19","pubTimestamp":1780553995,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，长风药业涨超5%，截至发稿，涨5.55%，报21.3港元，成交额566.32万港元。消息面上，近日，长风药业发布公告，ICF004吸入粉雾剂I类新药临床试验申请近期已获得中国国家药品监督管理局批准。该产品的IND批准标志着集团吸入创新候选药物进入临床开发阶段，是具有长远战略意义的重要里程碑。凭借潜在的全球首创作用机制，该产品采用吸入干粉给药途径，旨在将药物直接递送至肺部病变区域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","VXUS","BK1191","IND","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149517693","title":"长风药业5月股份变动月报表：总股本维持不变，回购551,000股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1149517693","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149517693?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:02","pubTimestamp":1780477323,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年6月3日披露截至2026年5月31日止的股份变动月报表。本月公司注册股本总数仍为人民币411,978,387股，与上月底保持一致。在已发行股份方面，长风药业本月无新增发行活动。本次回购的股份并未注销，仍处于库藏状态。公司表示已遵守香港联合交易所有限公司的相关上市规则及法规；公告由执行董事及联席公司秘书朱玉玉签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115637538","title":"长风药业拟回购不超过已发行H股10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115637538","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115637538?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:55","pubTimestamp":1780412159,"startTime":"0","endTime":"0","summary":"长风药业于最新公告中披露，董事会拟在即将召开的股东周年大会上提请特别决议，以回购不超过公司已发行H股总数10%的股份。根据公告，长风药业过去六个月内，H股最高股价约48.80港元，最低约18.10港元。在股东大会召开前夕，公司将于2026年6月23日至6月26日暂停办理股份过户登记。有意参加该会议并就回购授权投票的股东需于2026年6月22日(星期一)下午四时三十分前办理完毕股份过户手续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业拟回购不超过已发行H股10%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115113464","title":"异动解读 | 长风药业新药临床试验获批但前景未明，盘中大跌6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115113464","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115113464?lang=zh_cn&edition=full","pubTime":"2026-06-01 09:36","pubTimestamp":1780277803,"startTime":"0","endTime":"0","summary":"长风药业(02652)今日盘中股价大幅下挫6.48%，引发市场关注。消息面上，公司宣布其ICF004吸入粉雾剂的I类新药临床试验(IND)申请已获得中国国家药品监督管理局(NMPA)批准。该产品拟用于治疗间质性肺病，包括特发性肺纤维化及进行性肺纤维化。然而，公司同时指出，相关的临床前结果尚属初步阶段，其能否成功转化为人体的安全性与疗效，仍有待后续临床试验的验证。市场分析认为，尽管新药获批进入临床试验阶段是研发进程中的关键一步，但公告中强调的“初步阶段”及未来疗效的不确定性，可能引发了投资者对研发风险和潜在失败的担忧，从而导致股价在交易时段内承压下跌。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640849981","title":"长风药业(02652)：NMPA批准ICF004 I类新药IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2640849981","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640849981?lang=zh_cn&edition=full","pubTime":"2026-06-01 08:07","pubTimestamp":1780272425,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布公告，ICF004吸入粉雾剂之I类新药临床试验申请近期已获得中国国家药品监督管理局批准。该产品拟用于治疗间质性肺病，包括但不限于特发性肺纤维化及进行性肺纤维化。ILD的特征为呼吸系统症状进行性加重及肺功能不可逆性下降，导致预后较差。该产品的IND批准标志着集团吸入创新候选药物进入临床开发阶段，是具有长远战略意义的重要里程碑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IND","02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2639673947","title":"长风药业(02652)：张晶晶获建议提名为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673947","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639673947?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:17","pubTimestamp":1780064270,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，陈鹏辉先生(陈先生)因希望投放更多时间于其他专业事务，已辞任非执行董事，自2026年5月29日起生效。张晶晶女士(张女士)因获建议提名为本公司执行董事，已辞任本公司监事及本公司监事会主席，自2026年5月29日起生效。于2026年5月29日举行的董事会会议上，董事会议决提名张女士为执行董事候选人;及于2026年5月29日举行的监事会会议上，监事会议决提名郑耀先生(郑先生)为监事及监事会主席候选人，并各自将于股东周年大会上提呈股东考虑及批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448078.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119006268","title":"长风药业回购4.55万股股份，耗资约94.04万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1119006268","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119006268?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:07","pubTimestamp":1780056451,"startTime":"0","endTime":"0","summary":"长风药业于2026年5月29日发布公告，披露其于当日于香港联交所场内回购普通H股4.55万股，占前一交易日已发行股本的0.0151%。本次回购每股价格介乎港币19.81元至20.88元，总金额约94.04万港元。公告显示，本次回购前，公司已发行股份总数为301,053,086股，库藏股数量为1,170,500股；回购后，已发行股份总数变为301,007,586股，库藏股数量升至1,216,000股。根据公告，回购后再度进行新股发行或库藏股出售、转让的相关禁售期将持续至2026年6月28日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"长风药业回购4.55万股股份，耗资约94.04万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638693801","title":"长风药业(02652)5月28日耗资约129.28万港元回购6.45万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638693801","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638693801?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:18","pubTimestamp":1779970686,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)公布，2026年5月28日耗资约129.28万港元回购6.45万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147202580","title":"长风药业：5月28日回购6.45万股股份，耗资约129.28万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1147202580","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147202580?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:15","pubTimestamp":1779970552,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年5月28日发布公告，称公司当日在香港联交所回购6.45万股H股，占此前已发行股份约0.0214%。本次回购价格介于每股19.4港元至20.36港元之间，总涉资约129.28万港元。本次回购基于2025年12月16日股东大会通过的购回授权，授权可回购股票总数为30222358股，目前已累计回购1170500股，占该授权通过当日公司已发行股份总数的约0.3873%。公司表示，本次股份回购已依照相关法律法规及香港联交所上市规则的规定进行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业：5月28日回购6.45万股股份，耗资约129.28万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638637347","title":"长风药业(02652)：CF017于东南亚市场递交上市许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2638637347","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638637347?lang=zh_cn&edition=full","pubTime":"2026-05-28 08:05","pubTimestamp":1779926715,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，本集团近期已向东南亚相关药品监管机构，递交CF017吸入用布地奈德混悬液的上市许可申请。CF017已于2021年5月获中华人民共和国国家药品监督管理局批准上市，其后在国内实现商业化销售。东南亚地区人口基数庞大且不断增长，医疗需求持续增长，呼吸疾病发病率不断攀升，是高品质吸入制剂极具发展潜力的市场。本公司认为，CF017于东南亚市场递交上市许可申请，标志本集团拓展国际商业化版图布局的全球化战略再迈新台阶。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169386513","title":"长风药业回购3.75万股股份，涉资约73.87万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169386513","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169386513?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:12","pubTimestamp":1779883952,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年5月27日发布翌日披露报表，公告显示公司于当日在香港联交所场内购回3.75万股股份，约占此前已发行股本的0.0125%。购回价格介乎每股19.49港元至20.38港元，合计付出约73.87万港元。回购后，公司已发行股本减少至301117586股，库藏股则增至1106000股，总股本维持302223586股不变。公告同时披露，回购授权于2025年12月16日获股东大会通过，总回购上限为30222358股。公司在公告中确认，已遵守香港联交所上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业回购3.75万股股份，涉资约73.87万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156389004","title":"长风药业5月26日回购6.75万股，耗资约135.44万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156389004","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156389004?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:31","pubTimestamp":1779798683,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年5月26日发布公告，披露公司当日在香港联交所回购普通股6.75万股，占该日前已发行股份约0.0224%。本次回购的价格区间为每股港币18.9元至20.38元，合共支出约135.44万港元。回购完成后，公司已发行股份数为301,155,086股，库藏股数增至1,068,500股，总股本保持302,223,586股。根据公司2025年12月16日通过的回购授权，公司可回购股份总数为30,222,358股，目前已累计回购1,068,500股，占授权通过当日公司已发行股份总数的约0.3535%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业5月26日回购6.75万股，耗资约135.44万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638142255","title":"长风药业(02652)5月26日斥资135.44万港元回购6.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638142255","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638142255?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:21","pubTimestamp":1779798110,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年5月26日该公司斥资135.44万港元回购6.75万股，回购价格为每股18.90-20.38港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638565805","title":"长风药业(02652)：NMPA受理噻托溴铵吸入粉雾剂的上市许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2638565805","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638565805?lang=zh_cn&edition=full","pubTime":"2026-05-26 08:12","pubTimestamp":1779754321,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布公告，本公司噻托溴铵吸入粉雾剂(该产品)的上市许可申请已获中华人民共和国国家药品监督管理局受理。该产品经特定的吸入装置递送至深肺部位。噻托溴铵吸入粉雾剂系全球用于治疗COPD的最广泛处方的吸入制剂品种之一。该产品报产，标志着本公司在COPD治疗领域的吸入制剂产品矩阵进一步完善，产品线覆盖度与治疗纵深持续拓展，巩固了在大呼吸道制剂领域的专业布局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cfpharmtech.com","stockEarnings":[{"period":"1week","weight":-0.0653},{"period":"1month","weight":-0.1301},{"period":"3month","weight":-0.3431},{"period":"6month","weight":-0.4691},{"period":"1year","weight":0.2915},{"period":"ytd","weight":-0.4557}],"compareEarnings":[{"period":"1week","weight":-0.0565},{"period":"1month","weight":-0.0693},{"period":"3month","weight":-0.0515},{"period":"6month","weight":-0.0378},{"period":"1year","weight":0.0159},{"period":"ytd","weight":-0.0415}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长风药业股份有限公司是一家专注于吸入技术及吸入药物的研发、生产及商业化的中国公司。该公司的产品组合主要针对呼吸系统疾病，包括哮喘、慢性阻塞性肺病（COPD）和过敏性鼻炎。该公司主要产品包括CF017，即治疗支气管哮喘的吸入用布地奈德混悬液，以及CF018，一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"长风药业","nameEN":"CF PHARMTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长风药业,02652,长风药业股票,长风药业股票老虎,长风药业股票老虎国际,长风药业行情,长风药业股票行情,长风药业股价,长风药业股市,长风药业股票价格,长风药业股票交易,长风药业股票购买,长风药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}